SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-17-007581
Filing Date
2017-04-27
Accepted
2017-04-27 17:00:59
Documents
11
Period of Report
2017-06-06
Effectiveness Date
2017-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A srpt-def14a_20170606.htm DEF 14A 2679474
2 GRAPHIC g201704271827018641760.jpg GRAPHIC 53447
3 GRAPHIC g201704271826531141755.jpg GRAPHIC 3818
4 GRAPHIC g201704271826524151751.jpg GRAPHIC 3818
5 GRAPHIC g201704271826565611756.jpg GRAPHIC 6427
6 GRAPHIC g201704271827018251759.jpg GRAPHIC 73643
7 GRAPHIC g201704271826527421752.jpg GRAPHIC 2521
8 GRAPHIC g201704271826527451753.jpg GRAPHIC 3818
9 GRAPHIC g201704271826565641757.jpg GRAPHIC 6849
10 GRAPHIC g201704271826530411754.jpg GRAPHIC 2184
11 GRAPHIC g201704271827018021758.jpg GRAPHIC 2067
  Complete submission text file 0001564590-17-007581.txt   2900845
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14895 | Film No.: 17790048
SIC: 2834 Pharmaceutical Preparations